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Chemotherapy-induced senescent cancer cells engulf
other cells to enhance their survival
Crystal A. Tonnessen-Murray1, Wesley D. Frey1, Sonia G. Rao1, Ashkan Shahbandi1, Nathan A. Ungerleider1, Joy O. Olayiwola1, Lucas B. Murray1,
Benjamin T. Vinson2, Douglas B. Chrisey2, Christopher J. Lord3, and James G. Jackson1
In chemotherapy-treated breast cancer, wild-type p53 preferentially induces senescence over apoptosis, resulting in a
persisting cell population constituting residual disease that drives relapse and poor patient survival via the senescence-
associated secretory phenotype. Understanding the properties of tumor cells that allow survival after chemotherapy
treatment is paramount. Using time-lapse and confocal microscopy to observe interactions of cells in treated tumors, we
show here that chemotherapy-induced senescent cells frequently engulf both neighboring senescent or nonsenescent tumor
cells at a remarkable frequency. Engulfed cells are processed through the lysosome and broken down, and cells that have
engulfed others obtain a survival advantage. Gene expression analysis showed a marked up-regulation of conserved
macrophage-like program of engulfment in chemotherapy-induced senescent cell lines and tumors. Our data suggest
compelling explanations for how senescent cells persist in dormancy, how they manage the metabolically expensive process
of cytokine production that drives relapse in those tumors that respond the worst, and a function for their expanded
lysosomal compartment.
Introduction
In response to chemotherapy, TP53 wild-type human breast tu-
mors rarely undergo pathological complete response (Bertheau
et al., 2002, 2007; Chen et al., 2012; Esserman et al., 2012;
Nakamura et al., 2012; Wang et al., 2016; Goetz et al., 2017), and
these patients have poor survival (Ungerleider et al., 2018).
Further research using human patient samples and mouse
models has demonstrated that p53 wild-type breast tumors re-
spond to chemotherapy by entering cell cycle arrest and senes-
cencewith concomitant expression of cytokines and chemokines
of the senescence-associated secretory phenotype (SASP; te
Poele et al., 2002; Jackson et al., 2012; Tonnessen-Murray
et al., 2018). The SASP can promote tumorigenic properties
such as proliferation, survival, stemness, immune evasion, and
metastasis (Rodier et al., 2009; Achuthan et al., 2011; Cahu et al.,
2012; Canino et al., 2012; Toso et al., 2014; Rao and Jackson,
2016).
At present, it is not clear what imbues the capabilities of
survival, persistence, and the metabolically expensive process of
SASP production. Here, we show that chemotherapy-induced
senescent breast cancer cells are highly enriched for gene ex-
pression programs related to macrophages and phagocytosis.
Senescent cells engulf neighboring cells and process them to
their expanded lysosome compartment, suggesting an abundant
source of energy and building blocks for these cells that then
drive relapse and poor survival.
Results
Cell-in-cell structures are evident in chemotherapy-induced
senescent tumors and cell lines
When mice bearing mouse mammary tumor virus (MMTV)–
Wnt1 mammary tumors are treated with chemotherapy, senes-
cence and SASP are induced, and tumors have regions where
senescent, nonproliferating cells can be extensive and homoge-
neous, or adjacent to relapsing, Ki67-positive cells (Jackson et al.,
2012). To examine interactions among cells in treated mammary
tumors, we transplanted p53 wild-typeMMTV-Wnt1 tumors that
were transduced with lentiviruses expressing various GFP- and
mCherry-conjugated markers. After tumors formed, mice were
treated with doxorubicin to induce arrest and senescence as
previously shown (Jackson et al., 2012; Tonnessen-Murray et al.,
2018) and then harvested during the response. Using confocal
microscopy of sections, we observed structures consistent with
cells engulfed within other cells in the treated tumors. Among
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these was the red membrane of a cell expressing farnesylated
mCherry completely surrounding the nucleus of another cell
expressing histone H2B-GFP as viewed by z-stack imaging (Fig. 1
A). In another example, an H2B-mCherry cell appeared to be
entirely encapsulated within a cytoplasmic GFP-expressing cell
(Fig. 1 B). Cells were determined to be within the other cell when
the engulfing “predator” cell completely surrounded the en-
gulfed “prey” cell from all angles. In both examples, the DAPI-
stained nuclei of both cells are visible. Examples of images
considered negative (appearing engulfed within another cell on
one plane of view but not another) are shown in Fig. S1.
Intrigued by these observations, and because of difficulty in
quantifying sections of 3D tumors for cell-in-cell structures, we
further investigated this engulfment phenotype in mouse and
human breast cancer cell lines treated with chemotherapy
drugs. 8 d after doxorubicin treatment, MCF-7 and 4226 (a cell
line created from a p53 wild-type MMTV-Wnt1 tumor) were ∼70
and 97% positive, respectively, for senescence-associated
β-galactosidase (SA-βGAL), a widely used marker of senes-
cence (Dimri et al., 1995; Sharpless and Sherr, 2015), and had
increased expression of multiple cytokines and chemokines
of the SASP (Fig. S2, A–D). Mixed populations of GFP- and
mCherry-expressing cells were plated together for both 4226
and MCF-7 cell lines and then treated with or without doxoru-
bicin for 24 h. 8 d later, remarkably consistent with our ob-
servations in vivo (Fig. 1, A and B), we found that large,
senescent cells of one color contained large vesicles of the other
color. GFP-positive tumor cells containing not just mCherry
vesicles but also large, mCherry cells with intact, DAPI-positive
nuclei were frequently observed (Fig. 1, C and D, white arrow-
heads). These vesicles were rarely present in nontreated (NT)
proliferating cells (Fig. 1, C and D). These data demonstrate that
chemotherapy-induced senescent cells have large vesicles in
them that have evidently originated from other, neighboring
cells in the culture or tumor.
Chemotherapy-induced senescent cells completely engulf
neighboring cells at a high frequency
To determine more rigorously if cells that appeared to be en-
gulfed were actually completely within the engulfing cell, we
used confocal microscopy. Examining z-stack images, we found
that mCherry/DAPI-positive vesicles were indeed completely
within senescent, GFP-positive cells, as they were surrounded
entirely by GFP-positive cytoplasm, for both 4226 (Fig. 2 A and
Video 1) and MCF-7 (Fig. 2 B) cells. To better characterize the
origin of the cell-in-cell structures, we captured time-lapse
videos of senescent cells mixed with NT cells. We found nu-
merous instances of 4226 (Videos 2, 3, 4, and 5, as indicated in
Table S1, video guide) and MCF-7 (Videos 6 and 7) GFP-
expressing senescent cells engulfing nonsenescent mCherry
cells over the course of 30–92 h. Engulfed mCherry cells were
broken down over time and often completely degraded in 2–3 d.
In some instances, remnants persisted as smaller mCherry-
positive vesicles for up to a week.
We next quantitated the frequency of engulfment by cells
treated with other drugs known to induce senescent-like phe-
notypes (Chang et al., 1999a; Huang et al., 2009). We found that
within mixed cultures of GFP- and mCherry-expressing cells
made senescent by doxorubicin, paclitaxel, or their combination
(Fig. S2, E and F), GFP-expressing cells had engulfed at least one
DAPI-positive neighboring mCherry-expressing cell at rates
ranging from 14 to 23% for 4226 cells and 16 to 25% for MCF-7
cells (Fig. 2, C and D). Untreated cultures engulfed at ∼3–4%
(Fig. 2, C and D), which is consistent with the background rate of
senescence in proliferating cell lines (Chang et al., 1999a; Fig. S2,
G and H); however, other modes of engulfment by nonsenescent
cells could also be responsible and cannot be ruled out. Inter-
estingly, cells treated with nutlin, a small-molecule inhibitor of
MDM2 that activates p53 and some senescent phenotypes in the
absence of DNA damage or other stress (Vassilev et al., 2004; Fig.
S2, E–H) also induced robust engulfment (Fig. 2, C and D), in-
distinguishable from that observed after chemotherapy-induced
senescence (Fig. S2 I and Video 8). The percentages calculated in
Fig. 2 (C and D) are based on counts made at a single time point,
and only cells that have within them an entire cell with intact
nucleus were scored positive. These counts would exclude se-
nescent cells that had previously engulfed cells but are in later
stages of breakdown and lost DAPI staining. These strict criteria
result in what is certainly an underestimate of the actual fre-
quency of engulfment by senescent cells.
Apoptotic cells are often engulfed not just by “professional”
phagocytes such as macrophages, but also by other, nonprofes-
sional phagocytic cell types as well (Gray and Botelho, 2017). Our
observations and previous experiments using proliferating
breast cancer cell cultures suggested a very low apoptotic rate.
Further, nothing in numerous videos of engulfment by senes-
cent cells suggested that the engulfed cells were in any observ-
able stage of apoptosis (Videos 2, 3, 4, 5, 6, 7, 9, and 10). Breast
cancer cell lines treated with chemotherapy drugs or nutlin had
no evidence of cleaved caspase 3 or cleaved poly(ADP-ribose)
polymerase (PARP), two markers of apoptosis (Fig. S3). To
quantitatively determine the contribution of apoptotic cell
engulfment to overall rate of engulfment by senescent cells,
GFP-expressing cells were treated with doxorubicin to induce
senescent predators and then plated with NT mCherry prey
cells. Senescent GFP cells readily engulfed NT proliferating
mCherry cells at high rates: 34 and 17% for 4226 andMCF-7 cells,
respectively (Fig. 2, E and F). If apoptotic cells were being en-
gulfed by senescent cells, one would predict a lower rate of
engulfment when apoptosis was blocked. We treated 4226 cul-
tures with the pan-caspase inhibitor Q-VD-Oph to block apo-
ptosis and found no change in engulfment rate, suggesting that
apoptotic cells do not contribute substantially to the presence of
engulfed cells (Fig. 2 G).
In addition to a large percentage of senescent cells that had
engulfed another cell, we observed many examples of senescent
cells engulfing multiple entire cells (Fig. 2, H and I) or engulfing
cells being engulfed by other cells (Fig. 2 J). To determine how
long after doxorubicin treatment cells began to engulf, we per-
formed time course experiments that showed engulfment only
after induction of the senescence program at 4 d, reaching
maximum levels at day 6 (Fig. S2, A and C; and Fig. 2 K). Before 4
d, despite cells having DNA damage, p53 activation, expression
of p21, DNA damage signals, and many other phenotypes, these
Tonnessen-Murray et al. Journal of Cell Biology 3828
Senescent tumor cells engulf neighbors for survival https://doi.org/10.1083/jcb.201904051
Figure 1. Cell-in-cell structures are observed in doxorubicin-treated mouse mammary tumors and breast cancer cell lines. (A) Cells from an MMTV-
Wnt1 mammary tumor were plated and infected ex vivo in separate dishes with lentiviruses expressing either H2B-GFP or farnesylated-mCherry. Cells were
orthotopically transplanted into the #4 mammary fat pad of C57BL/6j mice, and after tumors formed, cells were mixed and transplanted again in more mice.
After these mosaic tumors formed with cells expressing two different markers, mice were treated with doxorubicin. Tumors were harvested during senescent
response, sectioned, DAPI stained, imaged on a confocal microscope in three channels, and merged. Z-stack projections display 14 images taken 2 µm apart
with a total z range of 24.12 µm. (B) Cells from a second MMTV-Wnt1 tumor were separately infected with lentiviruses expressing GFP and H2B-mCherry as in
A, and mosaic transplants composed of these cells were treated, harvested, and imaged. Z-stack projections display 21 images taken 2 µm apart with a total z
range of 38.82 µm. Scale bars in A and B represent 50 and 25 µm for wide-field and zoomed images, respectively. Representative images of cell-in-cell
structures are depicted. (C and D) Populations of breast cancer cell lines expressing GFP or mCherry were mixed and treated with doxorubicin (DOXO) for 24 h
as stated in Materials and methods. 8 d after DOXO addition, 4226 (C) and MCF-7 (D) cells were fixed and DAPI stained, imaged on a fluorescent microscope in
three channels, and merged. White arrowheads denote mCherry vesicles present within GFP-positive, senescent cells. Scale bar represents 50 µm.
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Figure 2. DNA damage, microtubule stress, and ectopic p53 activation induce senescence and engulfment of entire cells. (A and B) Doxorubicin
(DOXO)-treated, GFP-expressing 4226 (A) or MCF-7 (B) cells were co-plated on a glass coverslip with proliferating, mCherry-expressing cells. 7 d later,
coverslips were fixed with 4% formaldehyde and stained for DAPI. Confocal images were captured, and z-stack projections are shown adjacent; representative
images are shown. Scale bar represents 10 µm (A) and 20 µm (B). Z-stack projections display 76 images taken 0.2 µm apart totaling 15 µm for A, and 14 images
taken 1 µm apart with a total z range of 12.62 µm for B. (C)Mixed populations of GFP- and mCherry-expressing 4226 cells were plated simultaneously at a 1:8
ratio. When near confluence, cells were treated with DMSO, 0.75 µM doxorubicin (DOXO), 10 nM paclitaxel (pacl.), or both and washed off after 24 h. Nutlin to
a concentration of 15 µM was applied every other day until fixation and imaging. Average of four independent experiments is shown, error bars indicate SEM;
one-way ANOVA and Newman–Keuls posttest was used to determine significance; *, significant compared with DMSO treated. (D)MCF-7 cells were treated as
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cells did not engulf (Fig. 2 K). To determine if engulfing predator
cells were indeed senescent, we treated mixed cultures of GFP/
mCherry cells with doxorubicin, captured fluorescent images to
identify engulfing cells, and then stained the cells with SA-βGAL
and imaged in color bright field. In sequential fluorescent/SA-
βGAL images of the same cell, we found that engulfed cells were
visible both in the fluorescent channel and by SA-βGAL staining
(Fig. 2 L). Images from three breast cancer cell lines showed that
engulfing cells were highly positive for the senescence marker
SA-βGAL, consistent with the high percentage of SA-βGAL
positivity in these treated cultures (Fig. S2, G and H). In sum,
these data show that chemotherapy-induced senescent cells
engulf neighboring senescent cells and healthy/proliferating
cells at a high frequency.
Different cell types engulf after doxorubicin-induced
senescence
After discovering that doxorubicin-treatedMCF-7 and 4226 cells
engulf when senescent, we observed that another TP53 wild-
type breast cancer cell line, MPE600, also engulfed at a high
rate (Fig. 3 A). We next tested if TP53 mutant cells acquired the
engulfment phenotype. TP53 mutant cells are more sensitive to
DNA damage (Brown and Wouters, 1999; Bunz et al., 1999), but
cells that survive can undergo p53-independent senescence in
culture (Chang et al., 1999b). Indeed, we found that in two TP53
mutant breast cancer cell lines shown to become senescent after
chemotherapy, BT474 (Rosemblit et al., 2018) and T47D (Rastogi
et al., 2006), cells that survived chemotherapy could engulf
neighboring NT cells (Fig. 3, B and C). Two non–breast cell lines
that are TP53 wild type and undergo chemotherapy-induced
senescence, A549 lung adenocarcinoma and U2OS osteosar-
coma (Litwiniec et al., 2010; Anwar et al., 2018), also engulfed
neighboring NT cells 7–8 d after doxorubicin treatment (Fig. 3, D
and E). Lastly, MCF-7 cells with CRISPR-Cas9–edited TP53 alleles
have very few cells that survive chemotherapy, but those that do
also engulfed (Fig. 3 F). The TP53-edited MCF-7 cells that sur-
vived chemotherapy were SA-βGAL positive and adopted classic
morphological changes consistent with senescent cells (Fig. S2 J),
consistent with p53-independent senescence observed by others
(Chang et al., 1999b). These findings, taken together with pre-
vious studies, suggest that p53 promotes the near-term survival
of chemotherapy-treated cells that eventually develop the en-
gulfment phenotype but is not strictly required for the
phenotype.
Chemotherapy-induced senescent cells process engulfed cells
to the lysosome
Senescent cells have a vastly expanded lysosomal compart-
ment that is detected by the SA-βGAL assay (Kurz et al., 2000;
Lee et al., 2006), which is used widely as a marker for se-
nescence (Dimri et al., 1995; Sharpless and Sherr, 2015). We
showed that engulfing cells were SA-βGAL positive (Fig. 2 L);
thus, we surmised that the expanded lysosomal compartment
of senescent cells might be involved in processing engulfed
cells. To determine the fate of engulfed cells, we examined
cultures of senescent, GFP-positive breast cancer cells mixed
with NT “clear” cells that express no fluorescent protein.
Consistent with increased lysosomal activity detected by SA-
βGAL, LysoTracker staining was much brighter in senescent
cells compared with surrounding NT proliferating cells (Fig. 4
A). Engulfed cells were in various stages of dissolution within
senescent cells. Mostly intact engulfed cells stained weakly
for LysoTracker and positive for Hoechst (Fig. 4 A, orange
arrowhead); however, as engulfed cells became smaller,
Hoechst staining fragmented and the LysoTracker signal became
stronger (Fig. 4 A, yellow arrowhead), leading to DAPI-negative
and strong LysoTracker staining (Fig. 4 A, white arrowhead). In
4226 cells, ∼80% of engulfed cells were positive for LysoTracker
(Fig. 4 B).
To confirm these findings, we expressed GFP-tagged LAMP1,
a component of the lysosomal membrane, in MCF-7 cells. Cos-
taining with LysoTracker dye on LAMP1-GFP MCF-7 cells
showed nearly complete colocalization, confirming efficient
marking of the lysosome (Fig. S4). After treatment, we observed
that mCherry-H2B cells were enveloped within membranes
containing LAMP1-GFP expressed by the treated, senescent cell
(Fig. 4, C and D). Time-lapse videos show that LAMP1-GFP
membranes formed around engulfed cells (Videos 9 and 10).
in C using 0.25 µM doxorubicin, 5 nM paclitaxel, and 2.5 µM nutlin. Average of five independent experiments is shown; error bars indicate SEM;
one-way ANOVA and Newman–Keuls posttest were used to determine significance; *, significant compared with DMSO treated, P < 0.05. (E and F) 4226 and
MCF-7 cells were left untreated or treated with 0.75 and 0.25 µM doxorubicin, respectively, for 24 h. Either NT GFP-expressing cells were co-plated with
NT mCherry cells (NT, gray bar) or doxorubicin-treated GFP-expressing cells were co-plated with NT, proliferating mCherry cells (DOXO, purple bars). 7 d after
co-plating, cells were fixed and DAPI stained, and random fields were imaged by microscopy. Data shown are the percentage of GFP-expressing cells examined
that had one or more DAPI-positive, red vesicles inside them. Average of three independent experiments shown; error bars indicate SEM; significance de-
termined using unpaired t test; **, P < 0.001 (E); **, P < 0.005 (F). (G) 4226 cells were treated and plated as in F. 48 h before scoring, cultures were treated with
DMSO or 20 µMQV-D-Oph, a pan-caspase inhibitor. Average of three experiments are shown; not significant by unpaired t test, P = 0.46. (H) Confocal z-stack
image of MCF-7 as in B. Representative image of a cell with multiple engulfed cells is shown. Z-stack projections display 12 images taken 2 µm apart with a
total z range of 21.5 µm. Scale bar represents 20 µm. (I) Representative image of a senescent 4226 cell plated with NT 4226 cells as in F showing multiple
engulfed cells. Scale bar represents 10 µm. (J) Senescent MCF-7 cells were treated with doxorubicin and paclitaxel, as in D. Representative image of multiple
sequential engulfments shown. Scale bar represents 50 µm. (K) GFP-expressing MCF-7 cells were treated with 0.75 µM doxorubicin or not on day 0 for 24 h,
and then plated on day 1 with NTmCherry-expressing cells. On day 3, the 24-well plate was placed on an IncuCyte and imaged every 2 h until day 11. In cultures
of NT mCherry cells mixed with either treated GFP cells (purple line) or NT GFP cells (black line), four different random fields of viewwere quantified once each
day for mCherry cells within GFP cells. Error bar represents SEM; significance was determined by unpaired t test on each day; *, P < 0.05; nonsignificant P
values are shown in the figure. (L)Mixed cultures of GFP- and mCherry-expressing MCF-7, MPE600, and 4226 cells were plated and doxorubicin-treated as in C
and imaged for fluorescence 7 d later on a Cytation, followed by fixation, SA-βGAL staining, and repeat imaging in color bright field. Shown are examples of
matching sequential images of the same cell in fluorescence and color bright field. Arrowheads indicate engulfed cells visible in both images. Scale bars
represent 100 µm.
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Figure 3. Non–breast cancer cells and TP53mutant cells that survive doxorubicin treatment engulf neighbors. (A–E) The indicated GFP- or mCherry-
expressing cells were co-plated with cells of the opposite color as in Fig. 2 E that were either NT or doxorubicin treated (DOXO). After 7 d, images of engulfed
cells were captured (left) and random fields from triplicate wells were quantitated for engulfment (graphs, right). More than 100 treated cells were scored for
engulfment in each well and percentages determined. Error bars represent SEM. (F) mCherry-expressing MCF-7 cells with both alleles of TP53 edited by
CRISPR-Cas9 were doxorubicin treated as in A and co-plated with GFP-expressing MCF-7 cells. After 7 d, images were captured of representative remaining
TP53 edited cells that had engulfed.
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Blocking the acidification and activity of lysosomes with
the drug chloroquine resulted in increased frequency of cells
within cells in both senescent 4226 and MCF-7 cells, consis-
tent with an impairment in ability to degrade engulfed cells
(Fig. 4, E and F). Taken together, these data show that en-
gulfed cells are processed to the lysosome, and lysosome
acidification is necessary for the complete degradation of
engulfed cells.
Chemotherapy-induced senescent cells develop phagocytosis
proficiency but not entosis
Two modes of cell engulfment are entosis and phagocytosis. We
first examined entosis in chemotherapy-induced senescent cells.
As shown by others (Overholtzer et al., 2007), entosis was fre-
quent and easily identified in MCF-7 cells using standard assays
(Sun and Overholtzer, 2013). Entosis rates were not increased,
however, by doxorubicin treatment and induction of senescence
Figure 4. Engulfed cells are processed to the lysosome. (A) GFP-expressing 4226 cells were treated with 0.75 µM doxorubicin (DOXO) for 24 h and then
co-plated with clear (uninfected), NT 4226 cells. After 7 d, LysoTracker and Hoechst dye was added to cocultures, followed by imaging. Arrowheads indicate
clear cells within GFP-expressing senescent cells in various states of Hoechst and LysoTracker positivity. Scale bar represents 20 µm. (B) LysoTracker staining
was quantitated in three separate 4226 engulfment experiments. A total of 103 senescent cells were found to have engulfed another cell and were counted.
LysoTracker-positive vesicles that were both DAPI positive and completely surrounded by GFP cytoplasm from the engulfing cell were counted as positive,
while vesicles that were also completely surrounded by GFP and were DAPI positive but were not LysoTracker positive were counted as negative. Significance
determined by unpaired t test; **, P < 0.001. (C and D)MCF-7 cells expressing LAMP1-GFP were treated with doxorubicin and then co-plated with NTmCherry
cells. 7 d later, cells were fixed and confocal microscope images were captured in three channels and merged. Z-stack projections are shown adjacent and
below. Representative images shown. Scale bar represents 20 µm. Z-stack projections display 15 images taken 2 µm apart with a total z range of 28.02 µm for
C, 22 images taken 1 µm apart for a total of 20.48 µm (D, left), and 33 images taken 1 µm apart totaling 31.72 µm (D, right). (E and F) Cells expressing GFP were
doxorubicin treated or not for 24 h and then co-plated as in Fig. 2 (E and F). 5 d after plating, vehicle or chloroquine was added to final concentration of 20 or
10 µM for MCF-7 and 4226, respectively, and 2 d later MCF-7 (E) and 4226 (F) were fixed and DAPI stained. Engulfment percentage was determined for NT cells
mixed with NT cells (gray bar), doxorubicin-treated cells mixed with NT cells (DOXO, purple bars), and doxorubicin-treated cells mixed with NT cells followed
by chloroquine treatment (DOXO+CQ, green bars). Three (E) and five (F) individual experiments were performed; *, P < 0.05 determined by unpaired t test
between doxorubicin treated with or without chloroquine. Errors bars represent SEM.
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(Fig. 5, A and B), despite engulfment in monolayer cultures
being elevated 5- to 10-fold after doxorubicin treatment (Fig. 2,
C–F; and Fig. 3). Further, while senescent MPE600 and 4226
cells each engulf inmonolayer at rates higher thanMCF-7 (Fig. 2,
E and F; and Fig. 3 A), these cells underwent entosis at much
lower rates and showed no increase when senescent. As others
have shown (Overholtzer et al., 2007), inhibition of Rho-
associated kinases (ROCK) 1 and 2 using Y-27632 effectively
blocked entosis in MCF-7 (Fig. 5 A), but had little or no effect on
engulfment rates by senescent cells in monolayer (Fig. 5 C).
Lastly, E-cadherin (coded by the CDH1 gene) is required for and
forms concentrated foci at contact points of entosis (Overholtzer
et al., 2007; Sun et al., 2014a). We did not observe focal con-
centration of E-cadherin at contact points between senescent
predator cells that were actively engulfing and prey cells compared
with contacts formed by NT cells that do not engulf (Fig. 5 D).
Further, CDH1 knockout MCF-7 cells (Bajrami et al., 2018) engulfed
at the same rate as parental MCF-7 cells (Fig. 5, E–G).
To determine if senescent cells gained proficiency in phag-
ocytosis, we performed an established assay using apoptotic
Jurkat cells labeled with pHrodo dye that become fluorescent in
the acidic pH of the lysosome following phagocytosis (Aziz et al.,
2013). We found that doxorubicin-induced senescent 4226 cells,
but not NT cells, engulfed apoptotic Jurkat cells (and, to a lesser
extent, nonapoptotic Jurkat cells). Senescent cell engulfment
and lysosomal transport of Jurkat cells occurred at levels that
exceeded even that of RAW264 macrophages at the 48-h time
point (Fig. 6, A–C; and Fig. S5), perhaps at least partially due to
the large surface area of senescent cells (Fig. 6 A). To test if
senescent cells could engulf substrates other than senescent
cells, proliferating cells, and Jurkat cells, we applied fluorescent
dextran to cultures. We found a qualitative increase in dextran
uptake by senescent 4226 cells (Fig. 6 D). In sum, our data show
that entosis is unlikely to be the cause of the increased frequency
of cell-in-cell structures in chemotherapy-induced senescent
cells, and senescent cells gain proficiency in well-established
assays measuring phagocytosis.
Chemotherapy-induced senescent cells are highly enriched for
macrophage- and phagocytosis-related genes
To understand the molecular mechanisms altered in senescent
cells, RNA sequencing (RNA-seq) and gene set enrichment analysis
(GSEA) were performed on MMTV-Wnt1 tumors (Tonnessen-
Murray et al., 2018) and two cell lines, MCF-7 and 4226. Strik-
ingly, a potential program of engulfment was revealed. We previ-
ously showed that MMTV-Wnt1 tumors that are p53 mutant fail to
arrest after chemotherapy and undergo cell death and tumor re-
gression, while p53 wild-type tumors undergo senescence and
relapse quickly (Jackson et al., 2012). We found that the NT
p53 wild-type MMTV-Wnt1 tumors, MCF-7 cells, and 4226 cells
were highly enriched for expression of cell cycle genes (Fig. 7 A),
consistent with the arrest induced in treated tumors and cells
(Jackson et al., 2012; Tonnessen-Murray et al., 2018). Lysosome
signature was previously shown to be enriched in treated tumors
(Tonnessen-Murray et al., 2018) and was found to be highly en-
riched in both senescent MCF-7 and 4226 (Fig. 7 B). Remarkably,
treated p53 wild-type tumors, MCF-7, and 4226 had strong
enrichment for gene ontology categories GO_PHAGOCYTOSIS and
GO_PHAGOCYTOSIS_ENGULFMENT signatures (Fig. 7, C and D),
as well as a signature of genes related to how macrophages sense
their environment (Ley et al., 2016; Fig. 7 E). p53 mutant tumors
had a more modest enrichment (Fig. 7, C–E), consistent with other
senescence-related gene signatures in this genotype (Tonnessen-
Murray et al., 2018) and reflective of cell death occurring in p53
mutant cells that might have incurred enough cell damage to ac-
tivate the engulfment pathway (Tonnessen-Murray et al., 2018).
Cell engulfment, SA-βGAL–positive staining, and morpho-
logical changes become evident ∼3–5 d after doxorubicin
treatment (Figs. 2 K and S2, A and C); thus we performed
RNA-seq on treated 4226 cells before and after senescent/
engulfment phenotypes appeared (24 h and 8 d after doxo-
rubicin treatment). Interestingly, the lysosome, cell cycle, and
phagocytosis signatures were strongly enriched even at the
24-h time point, thus anticipating phenotypes that are not
present for approximately three or four more days. This delay
is reminiscent of the amount of time required for phenotypic
differentiation of neurons driven by acute gene expression
changes induced by retinoic acid (Encinas et al., 2000). Cell
cycle, lysosome, and phagocytic signatures were also evident
after nutlin treatment (Fig. 7 C), consistent with the engulf-
ment phenotype induced (Fig. 2, C and D; Fig. S2 I; and
Video 8).
Chemotherapy-induced senescent cells that have engulfed
have a survival advantage
Survival and persistence are characteristics of senescent cells
that likely contribute to their promotion of relapse (Tonnessen-
Murray et al., 2016). To determine whether senescent cells that
have engulfed other cells have superior persistence, MCF-7 and
4226 cells expressing GFP-tagged H2B were treated with doxo-
rubicin to induce senescence and then plated with NT cells ex-
pressing mCherry-H2B. 7 d later, live cells were single-cell
sorted into wells of a 96-well plate and confirmed microscopi-
cally to have only one cell per well. Each cell was scored mi-
croscopically as either GFP and mCherry positive (engulfed) or
GFP only (has not engulfed). Cells were followed over time and
marked as dead when they became rounded and/or fragmented
for >48 h (Fig. 8, B and D). Both 4226 and MCF-7 cells that were
double positive, and therefore had engulfed another cell, lived
longer in culture than those that had not (Fig. 8). These data
suggest that cell engulfment is beneficial to senescent cancer cell
viability. While only two cell lines were tested, the survival
phenotype after engulfment (Fig. 8, A and B) is consistent with
the ability of breast cancer cells that undergo senescence in
response to chemotherapy to avoid death, resulting in tumor
persistence and poor patient survival.
Discussion
Breast cancers are frequently wild type for TP53 (Shahbandi and
Jackson, 2019), and compelling evidence from our laboratory
and others shows that chemotherapy-treated breast cancers that
are TP53 wild type are more likely to have residual disease
(Bertheau et al., 2002, 2007; Chen et al., 2012; Esserman et al.,
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Figure 5. Engulfment by doxorubicin (DOXO)-induced senescent cells is distinct from e-cadherin–dependent entosis. (A and B) MCF-7, 4226, and
MPE600 cells, proliferating and 8 d after doxorubicin treatment, were placed in suspension in low-adhesion plates in the presence or absence of 10 µM ROCK
inhibitor Y-27632 (ROCKi) for 6 h, followed by cytospin, fixation, and imaging, along with cells cytospun immediately after suspension (0 h). (A) Number of
entosis cells and total number of cells from high-power phase fields were quantified and percentages were graphed. Individual data points are shown; error
bars represent SEM. Data represent at least two separate experiments. (B) Representative examples of NT cells and cells 8 d after doxorubicin (DOXO)
treatment undergoing entosis, denoted by white arrowheads. Scale bar represents 50 µm. (C) Indicated cell lines were doxorubicin treated and plated for
engulfment assays in triplicate as in Figs. 2 E and 3 A. In an additional group, 10 µM ROCK inhibitor Y-27632 was added every other day. Cultures were followed
up to 8 d after doxorubicin on an IncuCyte, and cell-in-cell structures were quantified and graphed on day 8. Graphs show mean percentages from triplicate
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2012; Nakamura et al., 2012; Wang et al., 2016; Goetz et al., 2017),
with senescent cells present (te Poele et al., 2002; Jackson et al.,
2012; Tonnessen-Murray et al., 2018), resulting in markedly
worse survival (Ungerleider et al., 2018). The present study
reveals a previously unknown ability of chemotherapy-induced
senescent cancer cells to engulf and degrade nearby cells, re-
sulting in enhanced survival and providing compelling ex-
planations for well-known but poorly understood senescent cell
phenotypes such as SASP and SA-βGAL staining.
Positive staining for SA-βGAL activity, caused by an ex-
panded lysosomal compartment (Kurz et al., 2000; Lee et al.,
2006), is a well-described feature of many senescent cell types,
both in vivo and in vitro, in normal and cancer cells (Jackson
et al., 2012; Sharpless and Sherr, 2015), including chemotherapy-
treated breast cancers (te Poele et al., 2002; Jackson et al., 2012;
Tonnessen-Murray et al., 2018). The function for this near-
ubiquitous feature of senescent cells was previously unclear,
but our observation of entire engulfed cells being processed to
the lysosome suggests an obvious purpose for lysosome expan-
sion. Indeed, we observed entire engulfed cells encapsulated in
lysosomal membrane (Fig. 4, C and D; and Videos 9 and 10).
Arrested senescent cells are highly metabolically active
(Quijano et al., 2012). Furthermore, these cells are metabolically
very different from nonsenescent cells (Zwerschke et al., 2003;
Erol, 2010; Kim et al., 2010, 2011; Quijano et al., 2012; Gey and
Seeger, 2013), producing and secreting cytokines and chemo-
kines that contribute to relapse (Jackson et al., 2012; Velarde
et al., 2013; Rao and Jackson, 2016). Although the mechanisms
employed by senescent cells that allow them to persist, survive,
and accommodate the energy-intensive processes involved in
translation, processing, and secretion of cytokines are not
completely understood, the engulfment and breakdown of other
cells is likely involved. We propose this process as a potential
source of energy and building blocks for the secretory pheno-
type and enhanced survival, and thus as a source for therapeutic
opportunities. This is supported by our finding that senescent
cells that have not engulfed another cell die earlier in culture.
There are many observed types of cell engulfment, including
phagocytosis and efferocytosis of apoptotic or dying cells by
macrophages or other nonprofessional phagocytes (Gray and
Botelho, 2017), emperipolesis, and entosis (Overholtzer et al.,
2007; Krishna and Overholtzer, 2016; Durgan et al., 2017;
Hamann et al., 2017). Our data show that senescent cells acquire
a phagocytic phenotype ultimately targeting nonapoptotic
cancer cells, superficially similar to entosis. Entosis was de-
scribed as cannibalism by cancer cells in culture after loss of
substrate adherence, sometimes resulting in death of the en-
gulfing cell and sometimes lysosomal degradation of the en-
gulfed cell (Overholtzer et al., 2007; Krishna and Overholtzer,
2016). Rates of entosis can be increased by glucose starvation
(Hamann et al., 2017) or 12–48 h after radiation/chemotherapy
treatment (Martins et al., 2018). Breast cancer cells in 3D culture
were shown to engulf bone marrow–derived mesenchymal
stem/stromal cells. Following the engulfment, dormancy and
senescent phenotypes were then induced in the engulfing breast
cancer cell (Bartosh et al., 2016).
The phenotype we show here shares some attributes with
entosis and may be related, but it differs in important ways.
Breast cancer cells showed no increase in entosis rates after
induction of senescence following chemotherapy treatment,
even though these cells show markedly elevated rates of en-
gulfment in monolayer. Further, breast cancer cells that did not
undergo entosis could still engulf when senescent, and engulf-
ment was independent of E-cadherin (Fig. 5), unlike entosis
(Overholtzer et al., 2007; Sun et al., 2014a). Our phenotype was
induced over time by chemotherapy treatment and senescence,
not acutely after loss of substrate adherence (Overholtzer et al.,
2007) or mitotic rounding (Durgan et al., 2017). Rather than
increasing engulfment relatively quickly due to physical changes
caused by loss of substrate adherence that result in cells that
happen to be highly deformable in suspension ingesting cells that
are less deformable (Sun et al., 2014b), our phenotype required
days to develop and was driven by a macrophage/phagocytosis
gene signature in vitro and in vivo. Evidence we present here
suggests that entosis and senescent cell engulfment, while sim-
ilar in some ways, are fundamentally different.
Engulfment by senescent cells increased their survival and
could provide building blocks that might enable SASP to drive
relapse. These factors suggest immediate clinical relevance, as
p53-mediated induction of senescence contributes to poor re-
sponse (Bertheau et al., 2002; Jackson et al., 2012) and poor
survival (Ungerleider et al., 2018) of breast cancer patients.
Materials and methods
Mice
All experiments were approved by the Tulane Institutional
Animal Care and Use Committee, Protocol ID# 4381, and
wells (all three data points are shown) of GFP-expressing cells (NT or DOXO) with an NT mCherry-expressing cell inside them. Error bars represent SEM. Data
shown are representative of at least two independent experiments. (D) Untreated GFP-expressing MCF-7 cells (NT) were plated as in Fig. 2 E with NT or
doxorubicin-treated (DOXO) clear MCF-7 parental cells. Cultures were followed for 5 d on IncuCyte, and cells were fixed, stained for e-cadherin (CDH1), and
imaged on IncuCyte again. Shown are representative images of senescent clear cells that had previously engulfed another cell (indicated by arrowheads,
verified in time lapse to be a live cell engulfment) making contact with NT cells (top two panels; open arrowhead indicates an NT cell intruding into the
senescent cell). Lower panel shows e-cadherin staining of contacts made between NT clear and NT GFP-expressing cells. (E)MCF-7 cells with knockout of the
gene for e-cadherin (CDH1-KO) and the parental line from which they were derived were stained for E-cadherin. Scale bar represents 50 µm. (F) GFP- and
mCherry-expressing MCF-7 parental and CDH1-KO cell lines were plated and doxorubicin treated in triplicate as in Fig. 2 C. Cultures were imaged on IncuCyte,
and 6 d after doxorubicin, cell-in-cell structures were quantified and graphed to showmean percentages of GFP-expressing cells (NT-NT or DOXO-DOXO) with
an mCherry-expressing cell inside them (all three data points are shown). Error bars represent SEM. Data shown are representative of two independent
experiments. (G) Representative images of engulfments occurring in cultures from F. Arrowheads indicate engulfed treated cells within other treated cells from
both MCF-7 parental and CDH1-KO cells. Scale bar represents 100 µm. Data shown are representative of at least two independent experiments.
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Figure 6. Doxorubicin (DOXO)-induced senescent cells are proficient in phagocytosis. (A–C) pHrodo-labeled Jurkat cells that were NT (nonapoptotic) or
treated with doxorubicin for 24 h (apoptotic) were placed onto cultures of RAW264 macrophages and proliferating and senescent 4226 cells. After 2 d, Jurkats
were washed off and plates were imaged and quantitated on IncuCyte for the red fluorescence emitted after the phagocytosis of Jurkat cells and their transport
to lysosome. (A) Representative images of doxorubicin-treated, senescent 4226 cells (DOXO), NT 4226 cells, and RAW264 macrophage cell line. Scale bar
represents 200 µm. (B) Representative phase and red fluorescence images were captured over a time course of a senescent 4226 cell engulfing pHrodo-labeled
cells and processing them to the lysosome. Scale bar represents 100 µm; time of capture after addition of pHrodo Jurkats is shown. Open arrowheads indicate
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conformed to the guidelines of the United States AnimalWelfare
Act and the National Institutes of Health. For tumor transplants
performed as previously described (Tonnessen-Murray et al.,
2018), ∼4 × 106 cells from cryopreserved MMTV-Wnt1 tumors
were resuspended inMatrigel (Corning) and injected into the #4
mammary fat pad. Tumors formed after 2–3 wk, and when they
became ∼1.25 cm, they were excised, minced, trypsinized for
10 min, and filtered through a 100-µm filter. Multiple concen-
trations of cells ranging from 2 × 105 to 2 × 106 were plated in a
well of a 6-well plate (many of these cells just extracted from the
tumor were nonviable). After transduction and FACS to purify a
fluorescent population (Tonnessen-Murray et al., 2018), cells
were injected into the mammary fat pad of C57BL/6j mice for
passaging or doxorubicin treatment as previously described
(Jackson et al., 2012; Tonnessen-Murray et al., 2018). For Fig. 1, a
total of six MMTV-Wnt1 doxorubicin-treated, mixed color tu-
mors were harvested. 10 random fields of view were imaged for
each sample.
Lentiviral infections
Fluorescent protein inserts (cytoplasmic GFP and mCherry, in
the backbone CD502A-1 [pCDH-EF1α-MCS cDNA Single Pro-
moter Cloning and Expression Lentivector] from Systems Bio-
sciences; LAMP-GFP [34831]; mCherry-Farnesyl for membranes
[55045]; H2B-GFP [21210]; and H2B-mCherry [21217] from
Addgene) were cloned into plasmids used in our laboratory
previously (Tonnessen-Murray et al., 2018). Lentivirus was
produced using 293T cells and a standard calcium phosphate
transfection protocol, or with Lipofectamine 2000 according to
the manufacturer’s instructions (Thermo Fisher Scientific). Vi-
ral supernatants were collected 48 to 72 h after transfection and
filtered (0.45 µm), and then cells (ex vivo tumors or cell lines)
were infected in the presence of polybrene (8 µg/ml). Positive
cells were FACS sorted using a BD FACSAriaII as previously
published (Tonnessen-Murray et al., 2018).
Cell culture
MCF-7 cells were obtained from ATCC and cultured in complete
Eagle’s minimum essential medium (RRID: CVCL_0031; ATCC,
HTB-22). MPE600 cells (RRID: CVCL_9875) were a gift from Joe
Gray (Oregon Health Sciences University, Portland, OR) and
were cultured in complete DMEM. 4226 cells were created by
excision of a spontaneous MMTV-Wnt1 tumor, mincing, trypsi-
nizing, and plating, followed by passaging in complete DMEM
and eventual clonal outgrowth of the cell line. A549 (RRID:
CVCL_0023) was a gift from Joseph Lasky (Tulane School of
Medicine, New Orleans, LA); U2OS (RRID: CVCL_0042) was a gift
from Sean Lee (Tulane School of Medicine); RAW264 cells (RRID:
CVCL_4478) were a gift from Heather Machado (Tulane School of
Medicine); and each was cultured in complete DMEM. BT474
(RRID: CVCL_0179) and T47D (RRID: CVCL_0553) were ob-
tained from ATCC (HTB-20 and HTB-133, respectively) and
were cultured in complete RPMI 1640. Creation of MCF-7
CRISPR-Cas9 TP53 edited cells has been described (Ungerleider
et al., 2018), and data shown here are from a single cell clone
with biallelic editing and verified by sequencing to be TP53
c.[884_892delATCCACTAC; 885_892delTCCACTAC]. MCF-7
CDH1 KO cells have been described (Bajrami et al., 2018) and
were compared with the parental MCF-7 from which they were
derived. Cell lines were routinely confirmed to be mycoplasma
free by DAPI staining. Cell lines were treated with doxorubicin
for 24 h (0.25 µM for MCF-7, BT474, T47D, A549, and U2OS;
0.75 µM for 4226; 0.50 µM for MPE600), followed by PBS
washes and medium replenishment. For engulfment experi-
ments, dishes were washed four times and trypsinized, and
75,000 cells were added to each well of a 6-well dish that already
had respective NT cells plated the day before. Medium was
changed every other day. 7 d after co-plating, dishes were im-
aged. In some experiments, chloroquine (Sigma-Aldrich; C6628-
25G), 10 µM for 4226 and 20 µM for MCF-7, was added 48 h
before collection. 70 kD Dextran (Thermo Fisher Scientific;
D1864) was used at 60 µg/ml and LysoTracker Red DND-99
(Thermo Fisher Scientific; L7528) was added to 75 nM 1 h before
collection. Paclitaxel (Apex Bio) was used at 5 and 10 nM for
MCF-7 and 4226 cells, respectively. Nutlin-3a (Sigma-Aldrich;
444152) was refreshed every other day for the length of exper-
iment, at concentrations of 2.5 and 15 µM for MCF-7 and 4226,
respectively.
Cell engulfment
On the day indicated in Fig. 2 (C–G), cells were fixed with 4%
formaldehyde, permeabilized with Triton X-100, DAPI
stained, and imaged by epifluorescence or confocal micros-
copy. Cells were judged to have engulfed another cell if the
engulfed vesicle was positive for DAPI staining and com-
pletely surrounded by the cytoplasm/membrane of the en-
gulfing cell. For quantitative experiments, at least three
individual experiments were performed. Random fields of
view were imaged, and ≥50 senescent cells were counted as
engulfed or not engulfed for each condition per experiment.
For Figs. 2 K, 3, and 5, GFP- and mCherry-expressing cells were
treated and combined as detailed in the figure legends, and
images were captured on IncuCyte. Engulfment was determined
by presence of an mCherry structure inside a vesicle that was
observable in the GFP channel of a GFP cell. In Fig. 2 K, cells were
plated and imaged over a time course on the IncuCyte, and en-
gulfment percentage was determined as detailed in the figure
legend. Similar results were found in repeated experiments using
FACS sorting of double-positive (engulfed) versus single-positive
(not engulfed) senescent cells at days 4, 6, and 8 after doxorubicin
pHrodo Jurkats before engulfment, and closed arrowheads indicate pHrodo fluorescence activation at low pH, such as occurs in the lysosome. (C) Total red
fluorescence in each well was quantified and normalized to the cell number in each well. Themean and individual data points from triplicate wells were plotted;
error bar represents SEM. (D) Proliferating and senescent 4226 cells were serum starved for 1 h, 60 µg/ml of 70-kD Texas Red Dextran was added, 30 min later
cells were washed and fixed with 4% formaldehyde, and images were captured. Representative images shown. Scale bar represents 20 µm. Data shown are
representative of at least two independent experiments.
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addition. At least 45,000 events were counted per time point per
condition. Double-positive events were collected and confirmed to
be engulfed (rather than stuck together) microscopically (≥50
counted per sample). ROCK inhibitor Y-27632 (10 µM; Apex Bio)
was added to cells the day after plating and was changed every
other day.
Figure 7. Gene expression analysis of doxorubicin-treated tumors and cell lines reveals enrichment of phagocytosis signatures. (A–E) GSEA was
performed with RNA-seq data from MMTV-Wnt1 mammary tumors (p53 wild type, red line; p53-null, black line) for NT (Ctl) versus doxorubicin-treated cells
harvested 24 h after the final treatment (left panels); from control MCF-7 cells and MCF-7 cells 8 d after doxorubicin (0.5 µM) treatment (middle panels); and
from NT 4226 cells versus cells 24 h (green line) and 8 d (blue line) after doxorubicin (0.75 µM) or treated for 24 h (red line) and 8 d (yellow line) with nutlin
(15 µM every other day), as indicated. RNA-seq was performed on MCF-7 and 4226 using samples from three independent experiments each. RNA was
extracted from six doxorubicin-treated and six NT MMTV-Wnt1 tumor samples and sent for sequencing. GSEA was performed for “HALLMARK_E2F_TARGETS”
(A); KEGG_LYSOSOME (B); GO_PHAGOCYTOSIS_ENGULFMENT (C); GO_PHAGOCYTOSIS (D); and genes involved in macrophage sensing their environment as
listed in Ley et al. (2016) (E). Enrichment scores (ES) were plotted. Statistical analysis using GSEA software is provided as false discovery rate q values
(significance at false discovery rate q < 0.25) in Table S2. GO, gene ontology.
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Figure 8. Senescent cells that have engulfed a cell have a survival advantage. (A–D) H2B-GFP–expressing senescent 4226 (A and B) or MCF-7 (C and D)
cells were co-plated with NT H2B-mCherry–expressing 4226 and MCF-7 cells, respectively. 7 d after coplating, cells were trypsinized and sorted one cell per
well of a 96-well plate. Each cell was confirmed microscopically and marked as double positive (engulfed, black line) or GFP positive only (not engulfed, red line)
and followed over time. (A) Four individual experiments were sorted; a total of n = 23 double-positive and n = 30 GFP-only 4226 cells were followed. Sig-
nificance was determined by log-rank Mantel–Cox test, *, P < 0.05. (C) One experiment was sorted; a total of n = 47 double-positive and n = 50 GFP-only cells
were followed. Experiment terminated at 12 d. Significance was determined by log-rankMantel–Cox test, *, P < 0.05. Examples of GFP+-only cells that died are
shown in upper panels of B and D; examples of surviving GFP-expressing cells with an mCherry vesicle within them (red arrowhead) are shown in lower panels
of B and D. Scale bars represent 50 µm.
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Entosis
Entosis was assayed as previously described (Sun andOverholtzer,
2013). Briefly, cells were trypsinized, washed, and resuspended in
complete medium at 4 × 105 cells per milliliter. For entosis
after 6 h, 0.5 ml was plated in a well of a Costar 24-well Ultra-
Low attachment plate (Corning; 3473). After 6-h incubation,
cells were centrifuged and thoroughly resuspended in 400 µl
PBS, and then 200 µl was Cytospun onto a glass slide for 5 min
at 500 rpm. Cells on slides were fixed in 2% formaldehyde
(diluted from 16% methanol-free formaldehyde; Thermo
Fisher Scientific; 28908), and then mounted with a coverslip
in PBS. For the 0-h time point of entosis, cells were processed
for cytospin as above immediately after trypsinization. High-
power 20× fields (comprising ∼300 to 1,000 total cells each)
were captured on a phase-contrast Olympus microscope (be-
low). Cells undergoing entosis (a positive was scored as any
cell with one half or more of another cell body internalized
inside of it) and total cells were scored as previously described
(Sun and Overholtzer, 2013) and are shown as individual data
points. ROCK inhibitor Y-27632 (10 µM; Apex Bio) was added
to cells at the time of plating in low-adhesion plates.
Phagocytosis assay
Phagocytosis of pHrodo-labeled Jurkat cells was performed
essentially according to the manufacturer’s instructions (Essen
BioScience). Briefly, 4226 cells were made senescent as in Fig. 2
C. RAW264 cells were plated at 50,000 cells/48 wells. Jurkat
cells were plated in a 6-well plate at 106 cells/ml and then treated
or not with 1 µM doxorubicin for 24 h, and apoptosis was con-
firmed by Annexin V staining. Apoptotic or nonapoptotic Jurkats
were then stained with pHrodo dye according to the manu-
facturer’s instructions (Essen BioScience), and then 200,000 cells
were plated on top of RAW264 or proliferating 4226 cells plated
the day before or senescent 4226 cells. 2 d later, Jurkats were
washed off, fresh medium was replenished, and images were
captured at 20× on IncuCyte for red fluorescence and phase.
From IncuCtye images, cell number was determined, and then
total red object integrated intensity (red-calibrated unit
× μm2/image) was calculated for each well after masking us-
ing a red-calibrated unit threshold of 0.2 and an area
threshold of 1,000. The total red object intensity was then
divided by cell number to normalize the intensity in a well for
the number of cells in that well. Data are representative of at
least two independent experiments.
Microscopes
Cells were imaged on an Olympus inverted immunofluorescence
microscope (IX-71) with DP-70 camera using cellSens 1.12
Standard Imaging Software at room temperature using a 20× or
40× objective. Confocal imaging was performed on tissue sec-
tions or cells mounted in Prolong Diamond Antifade Mountant
(P36965; Thermo Fisher Scientific) on glass coverslips, using an
Olympus FV1000 with a Plan Apochromat N 60× oil objective.
Confocal microscopy was also performed using a Nikon TiE-2
Inverted Research Microscope and Nikon A1rSi Laser Point
Scanning Confocal, with a Plan Apochromat λ 60× oil objective
for cell lines and Plan Fluor 40× oil for tissue sections, and
NIS-Elements software. Videos were captured on a Carl Zeiss
Cell Observer inverted microscope with an LD Plan-Neofluar
20× objective using Axiovision software and an Olympus Viva-
view LCV110U with a Hamamatsu C10600 Orca-R2–controlled
cooled charge-coupled device camera, using 10× and 20× ob-
jectives, at 37°C and 5% CO2 in full growth medium. Cell images,
fluorescence data for pHrodo, and time course images were
captured on an IncuCyte S3 system using 2018A software ver-
sion, at 37°C and 5% CO2 in full growth medium at 10× or 20×
magnification. Cell images (37°C and 5% CO2), DAPI counts, and
color bright-field images for SA-βGAL stains (at 25°C and at-
mospheric CO2 in PBS at 20× magnification) were captured on a
Cytation5 using Gen5 software version 3.05. Videos were cropped
using Axiovision or ImageJ (National Institutes of Health). Image
brightness and background levels were adjusted uniformly for
whole images using Photoshop for visual clarity in publication
where necessary.
Gene expression analysis
Gene expression analysis of MMTV-Wnt1 tumors has been
described previously (Tonnessen-Murray et al., 2018). Briefly,
spontaneous tumors from mice that were treated or not with
doxorubicin were harvested (Jackson et al., 2012), RNA was
prepared with Trizol (Thermo Fisher Scientific) reagent, and
RNA-seq was performed by the MD Anderson Cancer Center
Sequencing and Microarray Facility (Houston, TX) as de-
scribed previously (Tonnessen-Murray et al., 2018). Cell lines
were plated, treated, and then harvested at time points as
indicated in the figures, and RNA was prepared using Trizol
reagent, as previously described (Jackson and Pereira-Smith,
2006). RNA-seq was performed by BGI (Shenzhen, China)
using BGISEQ-500, single-end 50-bp, 20 million reads per
sample (4226) and Hiseq 4000, paired-end 100-bp, one lane
100PE sequencing (MCF-7). Gene expression analysis using
GSEA software (http://software.broadinstitute.org/gsea/index.
jsp) was performed using the gene lists indicated in the fig-
ures, as previously described (Tonnessen-Murray et al., 2018).
Real-time PCR was performed on a QuantStudio6 (Applied Bio-
systems) using Sybr Green (Bio-Rad) and analysis as per Pfaffl
(2001), as previously described (Jackson et al., 2012).
Immunoblotting
Cell lines were treated and harvested as indicated in the figures.
Lysates were prepared using TNESV buffer (1% NP-40, 50 mM
Tris-HCl, pH 7.5, 100mMNaCl, 2 mMEDTA, and 10mMNaVO4;
Jackson et al., 1998), and 50 µg of total protein was separated by
10% SDS-PAGE and then transferred to nitrocellulose mem-
branes using Bio-Rad reagents and apparatus. Immunoblotting
was performed as previously described (Jackson and Yee, 1999)
for cleaved caspase 3 (rabbit polyclonal, 9661S; Cell Signaling),
PARP (rabbit polyclonal, 9542S; Cell Signaling), and actin
(mouse monoclonal, MA5-15739; Invitrogen). All antibodies
were used at 1:1,000 dilution.
Videos
Video 1 was reconstructed from images taken on an Olympus
FV100 confocal microscope using a Plan Apochromat N 60× oil
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objective. Videos 2, 6, 7, 9, and 10 were imaged on an Olympus
Viva-view LCV110U using a 10× objective for 2, 6, 9, and 10 and a
20× objective for 7. Videos 3, 4, and 5 were imaged on a Carl
Zeiss cell observer inverted microscope with an LD Plan-
Neofluar 20× objective. Video 8 was reconstructed using NIS-
Elements software from images taken on a Nikon A1rSi laser
point scanning confocal microscope with a Plan Apochromat λ
60× oil objective. All videos began 6–7 d after doxorubicin
treatment, unless otherwise noted. Videos were created of se-
nescent 4226 cells engulfing NT cells in seven independent ex-
periments, totaling 199 separate videos. Representative videos
of complete cell engulfment captured are shown. Videos were
created of senescent MCF-7 cells engulfing NT cells in three
separate experiments. One experiment was captured on an
IncuCyte and two other experiments were captured on other
microscopes mentioned above, totaling 35 videos.
Online supplemental material
Fig. S1 shows confocal images of MMTV-Wnt1 tumor sections
depicting examples of structures that would not be counted as
cells within cells. Fig. S2 shows images and quantifications of
SA-βGAL staining of 4226 and MCF-7 cells, real-time PCR of
SASP genes, and images of nutlin-induced senescent engulf-
ment. Fig. S3 contains images of Western immunoblots of PARP
and cleaved caspase 3 in chemotherapy-treated, senescent cul-
tures. Fig. S4 shows fluorescent images of cell engulfment by
senescent LAMP1-GFP MCF-7 cells also stained with Lyso-
Tracker. Fig. S5 shows two additional examples of individual,
senescent 4226 cells engulfing apoptotic Jurkat cells and pro-
cessing them to the lysosome where pHrodo fluorescence can be
imaged. Video 1 shows a 3D reconstruction of an engulfed 4226
cell; Videos 2, 3, 4, and 5 show engulfment by doxorubicin-
treated 4226 cells; Videos 6 and 7 show engulfment by
doxorubicin-treated MCF-7 cells; Video 8 depicts 3D recon-
struction of nutlin-induced senescence engulfment in 4226 cells;
and Videos 9 and 10 show doxorubicin-induced senescence en-
gulfment by LAMP1-GFP MCF-7 cells. Table S1 is a guide to the
supplemental videos. Table S2 contains the statistical analyses
corresponding to gene expression data in Fig. 7.
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